Drug Interactions
Expert-defined terms from the Professional Certificate in Medication Management (United Kingdom) course at LearnUNI. Free to read, free to share, paired with a professional course.
Absorption Interaction – Concept #
Alteration of drug uptake from the gastrointestinal tract. Related terms: bioavailability, first‑pass metabolism. Explanation: When a second agent modifies gastric pH, motility, or chelation, the amount of active drug entering systemic circulation changes. Example: Antacids decrease absorption of ketoconazole by raising gastric pH. Practical application: Assess timing of administration and advise separation of doses. Challenges: Variable patient diet and over‑the‑counter supplement use complicate prediction.
ACE Inhibitor Interaction – Concept #
Potentiation of hypotensive effects when combined with other agents that lower blood pressure. Related terms: angiotensin‑II receptor blockers, potassium‑sparing diuretics. Explanation: Concurrent use of ACE inhibitors with NSAIDs can blunt antihypertensive efficacy, while combination with potassium‑rich drugs raises hyperkalaemia risk. Example: Lisinopril plus spironolactone. Practical application: Monitor blood pressure and serum potassium after initiating therapy. Challenges: Renal dysfunction may amplify adverse outcomes.
Alcohol‑Drug Interaction – Concept #
Synergistic central nervous system (CNS) depression or metabolic competition. Related terms: Cytochrome P450, first‑pass effect. Explanation: Ethanol induces CYP2E1, increasing clearance of certain drugs, and competes for metabolic pathways, leading to accumulation of others. Example: Disulfiram‑alcohol reaction; benzodiazepines with alcohol causing profound sedation. Practical application: Counsel patients on abstinence or limited intake when prescribing CNS depressants. Challenges: Patient self‑reporting of alcohol consumption is often unreliable.
Antacids Interaction – Concept #
Reduction of drug dissolution and absorption through pH alteration or chelation. Related terms: hydrotalcite, magnesium hydroxide. Explanation: Antacids containing aluminium or magnesium bind to tetracyclines, fluoroquinolones, and iron salts, forming insoluble complexes. Example: Ciprofloxacin taken with calcium carbonate yields decreased plasma levels. Practical application: Separate dosing by at least two hours. Challenges: Patients may use antacids intermittently, making adherence monitoring difficult.
Anticholinergic Interaction – Concept #
Additive blockade of muscarinic receptors leading to enhanced anticholinergic toxicity. Related terms: dry mouth, urinary retention. Explanation: Co‑administration of drugs with anticholinergic properties (e.G., Antihistamines, tricyclic antidepressants) can precipitate confusion, delirium, or cardiac arrhythmias, especially in the elderly. Example: Diphenhydramine plus amitriptyline. Practical application: Use anticholinergic burden scales to guide prescribing. Challenges: Many over‑the‑counter products contribute to cumulative load.
Anticoagulant Interaction – Concept #
Alteration of coagulation cascade leading to increased bleeding or thrombosis risk. Related terms: warfarin, direct oral anticoagulants. Explanation: Drugs that induce or inhibit CYP2C9, CYP3A4, or affect vitamin K metabolism modify warfarin plasma levels. Example: Fluconazole inhibits CYP2C9, raising INR; rifampicin induces metabolism, lowering INR. Practical application: Schedule more frequent INR checks when new interacting agents are introduced. Challenges: Genetic polymorphisms of CYP enzymes cause inter‑patient variability.
Antifungal Interaction – Concept #
Potent inhibition or induction of CYP enzymes altering concomitant drug concentrations. Related terms: azole class, enzyme induction. Explanation: Azoles (ketoconazole, itraconazole) are strong CYP3A4 inhibitors, raising levels of statins, calcium channel blockers, and certain immunosuppressants. Conversely, terbinafine induces CYP2D6, reducing beta‑blocker efficacy. Example: Itraconazole plus simvastatin leading to rhabdomyolysis. Practical application: Consider alternative antifungal agents or dose adjustments. Challenges: Limited therapeutic alternatives for resistant fungal infections.
Antihypertensive Interaction – Concept #
Synergistic or antagonistic blood pressure effects when multiple agents are combined. Related terms: beta‑blockers, diuretics. Explanation: Additive hypotension can cause orthostatic falls; antagonism may arise when NSAIDs blunt diuretic response. Example: Furosemide with ibuprofen reduces natriuresis. Practical application: Monitor orthostatic vitals after regimen changes. Challenges: Comorbid pain conditions often necessitate NSAID use, creating a therapeutic dilemma.
Antiplatelet Interaction – Concept #
Enhanced bleeding risk when antiplatelet agents are combined with anticoagulants or NSAIDs. Related terms: aspirin, clopidogrel. Explanation: Dual antiplatelet therapy (DAPT) plus a direct oral anticoagulant significantly raises gastrointestinal bleeding incidence. Example: Aspirin plus rivaroxaban. Practical application: Employ gastro‑protective strategies (PPI) and assess necessity of each agent. Challenges: Balancing thrombosis prevention against hemorrhagic complications.
Antipsychotic Interaction – Concept #
Pharmacokinetic or pharmacodynamic changes leading to extrapyramidal symptoms or QT prolongation. Related terms: CYP2D6, serotonin syndrome. Explanation: CYP2D6 inhibitors (paroxetine) increase plasma levels of risperidone, heightening side‑effects; co‑administration with other QT‑prolonging drugs (macrolides) augments arrhythmia risk. Example: Haloperidol plus fluoxetine. Practical application: Review medication list for CYP inhibitors before initiating antipsychotics. Challenges: Polypharmacy in psychiatric populations makes interactions common.
Antiretroviral Interaction – Concept #
Complex modulation of viral protease, reverse transcriptase, and integrase inhibitors via CYP pathways. Related terms: HAART, pharmacogenomics. Explanation: Protease inhibitors are strong CYP3A4 inhibitors, raising levels of statins and certain antihypertensives; non‑nucleoside reverse transcriptase inhibitors can induce CYP enzymes, lowering co‑administered drug concentrations. Example: Ritonavir plus simvastatin causing myopathy. Practical application: Use statins less dependent on CYP3A4 (e.G., Pravastatin). Challenges: Resistance patterns may limit choice of antiretroviral regimen, forcing high‑risk combinations.
Antitussive Interaction – Concept #
Central nervous system depression when combined with opioids or alcohol. Related terms: dextromethorphan, serotonin syndrome. Explanation: Dextromethorphan is a weak NMDA antagonist and a serotonin reuptake inhibitor; concurrent use with SSRIs can precipitate serotonin syndrome. Example: Dextromethorphan plus sertraline. Practical application: Advise patients to avoid OTC cough syrups while on serotonergic antidepressants. Challenges: Patients often self‑medicate for cough without informing clinicians.
Aspirin Interaction – Concept #
Increased bleeding risk and pharmacodynamic antagonism with anticoagulants, NSAIDs, and certain antihypertensives. Related terms: platelet inhibition, GI protection. Explanation: Low‑dose aspirin irreversibly inhibits COX‑1; adding clopidogrel or a DOAC compounds hemorrhagic potential. NSAIDs may compete for gastric mucosal protection, worsening ulcer risk. Example: Aspirin plus naproxen. Practical application: Prescribe proton‑pump inhibitors when dual therapy is unavoidable. Challenges: Balancing cardiovascular prophylaxis against gastrointestinal safety.
Beta‑Blocker Interaction – Concept #
Additive negative chronotropic and inotropic effects when combined with calcium channel blockers or digoxin. Related terms: verapamil, bradycardia. Explanation: Non‑dihydropyridine calcium channel blockers (verapamil, diltiazem) inhibit CYP2D6, raising beta‑blocker concentrations; together they may cause severe bradyarrhythmias. Example: Metoprolol plus verapamil. Practical application: Monitor heart rate and consider dose reduction of one agent. Challenges: Many patients with angina require both drug classes, necessitating careful titration.
Calcium Channel Blocker Interaction – Concept #
Metabolic inhibition leading to elevated levels of co‑administered drugs, and additive vasodilatory effects. Related terms: nimodipine, CYP3A4. Explanation: Diltiazem and verapamil inhibit CYP3A4, raising concentrations of statins, benzodiazepines, and certain immunosuppressants. Example: Diltiazem plus atorvastatin causing myopathy. Practical application: Select statins less reliant on CYP3A4 (e.G., Rosuvastatin) or adjust doses. Challenges: Dose adjustments may affect therapeutic efficacy of the primary antihypertensive.
Carbamazepine Interaction – Concept #
Strong enzyme inducer affecting a broad spectrum of drugs. Related terms: auto‑induction, hepatic metabolism. Explanation: Carbamazepine induces CYP3A4, CYP1A2, and CYP2C9, lowering plasma concentrations of oral contraceptives, warfarin, and certain antiretrovirals. Example: Reduced effectiveness of ethinyl estradiol leading to breakthrough bleeding. Practical application: Advise alternative contraceptive methods and monitor INR when starting carbamazepine. Challenges: Therapeutic drug monitoring for carbamazepine itself can be confounded by its own induction.
Catecholamine Interaction – Concept #
Potentiation or antagonism of sympathomimetic agents. Related terms: epinephrine, alpha‑agonists. Explanation: MAO inhibitors block degradation of catecholamines, intensifying the pressor response to tyramine‑rich foods and sympathomimetic drugs, risking hypertensive crisis. Example: Phenylephrine nasal spray taken while on phenelzine. Practical application: Restrict use of over‑the‑counter decongestants in patients on MAOIs. Challenges: Patient awareness of dietary restrictions is variable.
Cephalosporin Interaction – Concept #
Displacement of bilirubin from albumin and alteration of gut flora. Related terms: hyperbilirubinemia, Clostridioides difficile. Explanation: High‑dose ceftriaxone can displace bilirubin, precipitating kernicterus in neonates; broad‑spectrum cephalosporins disrupt microbiota, increasing risk of C. Difficile infection, especially when combined with proton‑pump inhibitors. Example: Ceftriaxone in a newborn leading to elevated bilirubin. Practical application: Avoid ceftriaxone in neonates and monitor bilirubin; implement antimicrobial stewardship. Challenges: Balancing infection control with stewardship mandates.
Cholesterol‑Lowering Interaction – Concept #
Statin metabolism affected by CYP inhibitors or inducers leading to myopathy or therapeutic failure. Related terms: HMG‑CoA reductase inhibitors, lovastatin. Explanation: Strong CYP3A4 inhibitors (e.G., Clarithromycin) raise simvastatin levels, increasing rhabdomyolysis risk; inducers (e.G., Carbamazepine) lower statin concentrations, reducing lipid‑lowering effect. Example: Simvastatin plus erythromycin causing muscle pain. Practical application: Select statins with minimal CYP interaction (e.G., Pravastatin) or adjust dosage. Challenges: Patient adherence to statin therapy can be compromised by side‑effects.
Cimetidine Interaction – Concept #
Broad‑spectrum inhibition of multiple CYP enzymes and renal tubular secretion. Related terms: histamine H2‑receptor antagonist, drug‑clearance. Explanation: Cimetidine elevates plasma concentrations of warfarin, phenytoin, theophylline, and certain benzodiazepines, heightening toxicity. Example: Increased theophylline levels leading to seizures. Practical application: Prefer famotidine, which has a more selective profile, when polypharmacy is present. Challenges: Many patients self‑medicate with OTC antacids, unaware of interaction potential.
Clarithromycin Interaction – Concept #
Potent inhibition of CYP3A4 and P‑glycoprotein affecting many cardiovascular and CNS agents. Related terms: macrolide antibiotic, QT prolongation. Explanation: Clarithromycin raises concentrations of statins, calcium channel blockers, and certain anti‑arrhythmics, increasing risk of myopathy or arrhythmia. Example: Clarithromycin plus amlodipine leading to hypotension. Practical application: Evaluate need for macrolide versus alternative antibiotic; adjust doses accordingly. Challenges: Resistance patterns may limit alternative choices.
Clopidogrel Interaction – Concept #
Reduced antiplatelet effect when CYP2C19 is inhibited, and increased bleeding risk when combined with anticoagulants. Related terms: prodrug activation, PPIs. Explanation: Proton‑pump inhibitors such as omeprazole inhibit CYP2C19, decreasing conversion of clopidogrel to its active metabolite, potentially leading to stent thrombosis. Example: Clopidogrel plus omeprazole reduces platelet inhibition. Practical application: Use pantoprazole or H2 antagonists instead. Challenges: Balancing gastro‑protection with antiplatelet efficacy.
COX‑2 Inhibitor Interaction – Concept #
Additive cardiovascular risk when combined with antihypertensives that raise blood pressure. Related terms: celecoxib, fluid retention. Explanation: Selective COX‑2 inhibitors can cause sodium and water retention, diminishing the effect of ACE inhibitors or diuretics, potentially worsening hypertension. Example: Celecoxib plus lisinopril leading to uncontrolled BP. Practical application: Monitor blood pressure after initiating COX‑2 inhibitors; consider alternative analgesics. Challenges: Patient preference for NSAIDs may conflict with cardiovascular safety.
Cyclosporine Interaction – Concept #
Narrow therapeutic index; metabolism heavily influenced by CYP3A4 and P‑glycoprotein. Related terms: immunosuppressant, nephrotoxicity. Explanation: CYP3A4 inhibitors (ketoconazole) dramatically raise cyclosporine levels, increasing nephrotoxicity; inducers (rifampicin) lower levels, risking graft rejection. Example: Cyclosporine plus fluconazole requiring dose reduction. Practical application: Perform therapeutic drug monitoring after any change in concomitant medications. Challenges: Frequent dose adjustments can be burdensome for transplant patients.
Digoxin Interaction – Concept #
Alterations in absorption, distribution, or renal clearance leading to toxicity or loss of efficacy. Related terms: cardiac glycoside, p‑glycoprotein. Explanation: Quinidine and verapamil inhibit P‑glycoprotein, raising digoxin concentrations; diuretics causing hypokalemia increase digoxin’s arrhythmogenic potential. Example: Digoxin plus furosemide causing digitalis toxicity. Practical application: Monitor serum digoxin levels and electrolytes when initiating interacting drugs. Challenges: Narrow therapeutic window makes dose titration critical.
Diuretic Interaction – Concept #
Electrolyte disturbances that influence the activity of other cardiovascular agents. Related terms: hypokalemia, hyperuricemia. Explanation: Thiazide diuretics can cause hypokalemia, potentiating the effect of digitalis and increasing the risk of arrhythmias; they also raise serum uric acid, potentially precipitating gout when combined with low‑dose aspirin. Example: Hydrochlorothiazide plus digoxin. Practical application: Supplement potassium or switch to potassium‑sparing diuretics when appropriate. Challenges: Patient adherence to electrolyte monitoring is often poor.
Dopamine Agonist Interaction – Concept #
Synergistic hypotension or nausea when combined with other dopamine‑modulating agents. Related terms: pramipexole, orthostatic hypotension. Explanation: Concomitant use of MAO‑B inhibitors (selegiline) and dopamine agonists may amplify dopaminergic side‑effects, such as nausea or severe hypotension. Example: Pramipexole plus rasagiline causing dizziness. Practical application: Start at low doses and titrate slowly; monitor blood pressure. Challenges: Parkinson’s disease patients often require polypharmacy, increasing interaction risk.
Enzyme Induction Interaction – Concept #
Increased metabolism of substrate drugs leading to reduced efficacy. Related terms: phenobarbital, phenytoin. Explanation: Strong inducers accelerate clearance of oral contraceptives, anticoagulants, and certain antiretrovirals, potentially resulting in therapeutic failure. Example: Phenobarbital decreasing plasma levels of warfarin, requiring higher INR targets. Practical application: Anticipate dose escalation or alternative therapy when initiating an inducer. Challenges: Induction may take weeks to manifest, complicating early detection.
Enzyme Inhibition Interaction – Concept #
Decreased metabolism causing drug accumulation and toxicity. Related terms: ketoconazole, fluoxetine. Explanation: Inhibitors of CYP3A4 or CYP2D6 raise concentrations of substrates, heightening adverse effect risk. Example: Fluoxetine plus venlafaxine leading to serotonin syndrome. Practical application: Review patient medication list for known inhibitors before prescribing high‑risk drugs. Challenges: Many inhibitors have dose‑dependent effects, requiring nuanced management.
Epinephrine Interaction – Concept #
Potentiation of vasoconstriction and tachycardia when combined with sympathomimetic agents. Related terms: alpha‑agonist, beta‑agonist. Explanation: Concomitant use of non‑selective β‑agonists (albuterol) and epinephrine can cause severe tachyarrhythmias, especially in patients with coronary artery disease. Example: Inhaled albuterol during anaphylaxis treatment with epinephrine. Practical application: Limit β‑agonist doses and monitor cardiac rhythm. Challenges: Emergency settings often prioritize rapid treatment over interaction considerations.
Erythromycin Interaction – Concept #
Strong CYP3A4 inhibition affecting cardiovascular and CNS drugs. Explanation: Erythromycin raises levels of statins, calcium channel blockers, and certain anti‑arrhythmics, increasing risk of myopathy and torsades de pointes. Example: Erythromycin plus simvastatin causing muscle breakdown. Practical application: Consider azithromycin, which has less CYP involvement, when interactions are a concern. Challenges: Resistance patterns may dictate erythromycin use despite interaction risk.
Estrogen‑Containing Oral Contraceptive Interaction – Concept #
Reduced efficacy when hepatic enzyme inducers increase steroid metabolism. Related terms: ethinyl estradiol, progestin. Explanation: CYP3A4 inducers such as rifampicin, carbamazepine, and St. John’s wort accelerate estrogen clearance, causing breakthrough bleeding and possible unintended pregnancy. Example: A woman on carbamazepine experiencing contraceptive failure. Practical application: Recommend barrier methods or non‑hormonal contraception while on inducers. Challenges: Patient may be unaware of the need for additional protection.
Fibrate Interaction – Concept #
Additive risk of myopathy when combined with statins, especially those metabolised by CYP3A4. Related terms: gemfibrozil, muscle toxicity. Explanation: Gemfibrozil inhibits glucuronidation of statins, markedly increasing plasma concentrations and myopathic risk. Example: Gemfibrozil plus atorvastatin leading to rhabdomyolysis. Practical application: Avoid concurrent use; if combination is essential, select a statin with minimal interaction (e.G., Pravastatin) and monitor CK levels. Challenges: Dyslipidaemia often requires multi‑agent therapy.
Fluconazole Interaction – Concept #
Potent CYP2C9 and CYP3A4 inhibition affecting warfarin, benzodiazepines, and certain antiretrovirals. Related terms: azole antifungal, drug‑clearance. Explanation: Fluconazole raises warfarin INR, increasing bleeding risk; it also elevates levels of midazolam, causing prolonged sedation. Example: Fluconazole plus warfarin requiring dose reduction. Practical application: Check INR more frequently after initiating fluconazole and adjust anticoagulant dosing. Challenges: Fungal infections may necessitate prolonged azole therapy, requiring ongoing monitoring.
Fluoxetine Interaction – Concept #
Strong inhibition of CYP2D6 and moderate inhibition of CYP2C19, influencing antidepressants and analgesics. Related terms: SSRI, serotonin syndrome. Explanation: Fluoxetine increases plasma concentrations of tricyclic antidepressants, beta‑blockers, and codeine (by reducing conversion to morphine). Example: Fluoxetine plus codeine resulting in inadequate analgesia. Practical application: Consider alternative analgesics or adjust doses. Challenges: Long half‑life of fluoxetine means interaction potential persists after discontinuation.
Furosemide Interaction – Concept #
Electrolyte depletion that can potentiate the cardiac toxicity of other drugs. Related terms: loop diuretic, hypokalemia. Explanation: Furosemide‑induced hypokalemia enhances digoxin toxicity and may increase the arrhythmic potential of certain anti‑arrhythmics. Example: Patient on digoxin developing bradyarrhythmia after high‑dose furosemide. Practical application: Monitor electrolytes and consider potassium supplementation. Challenges: Adherence to regular blood tests is often suboptimal.
GABAergic Interaction – Concept #
Additive CNS depression when multiple GABA‑modulating agents are combined. Related terms: benzodiazepine, barbiturate. Explanation: Co‑administration of benzodiazepines with alcohol, opioids, or gabapentinoids can cause profound sedation, respiratory depression, and increased fall risk. Example: Lorazepam plus gabapentin leading to excessive drowsiness. Practical application: Limit concurrent use, start with lowest possible doses, and educate patients about sedation. Challenges: Many patients with chronic pain or anxiety receive multiple GABAergic prescriptions.
Glucocorticoid Interaction – Concept #
Metabolic induction of hepatic enzymes and antagonism of certain antihypertensives. Related terms: prednisone, cushingoid effect. Explanation: Systemic steroids induce CYP3A4, lowering concentrations of oral contraceptives and some antiretrovirals; they also cause fluid retention, counteracting the antihypertensive effect of diuretics. Example: Prednisone reducing efficacy of ethinyl estradiol. Practical application: Consider alternative contraceptive methods and monitor blood pressure. Challenges: Steroids are often prescribed for short courses, yet interaction risk may be overlooked.
Glyburide Interaction – Concept #
Hypoglycaemia risk when combined with CYP2C9 inhibitors or drugs that displace protein binding. Related terms: sulfonylurea, renal clearance. Explanation: Fluconazole inhibits CYP2C9, raising glyburide levels and causing severe hypoglycaemia; NSAIDs may compete for albumin binding, further increasing free drug. Example: Patient on glyburide developing low blood glucose after starting fluconazole. Practical application: Monitor glucose closely and adjust sulfonylurea dose as needed. Challenges: Elderly patients may have diminished renal function, amplifying risk.
Griseofulvin Interaction – Concept #
Enzyme induction leading to reduced plasma concentrations of many drugs. Related terms: antifungal, CYP induction. Explanation: Griseofulvir induces CYP2C9, CYP2C19, and CYP3A4, decreasing effectiveness of warfarin, oral contraceptives, and certain antihistamines. Example: Reduced INR in a patient on warfarin after starting griseofulvin. Practical application: Increase warfarin dose or switch antifungal. Challenges: Griseofulvin is less commonly used now, but still prescribed for dermatophyte infections.
Heparin Interaction – Concept #
Altered anticoagulant effect when combined with antiplatelet agents or drugs that affect platelet function. Related terms: LMWH, bleeding risk. Explanation: Concomitant aspirin or clopidogrel increases risk of gastrointestinal bleeding; certain antibiotics (e.G., Ceftriaxone) may potentiate heparin’s effect via unknown mechanisms. Example: Patient on heparin and aspirin developing melena. Practical application: Assess need for dual therapy and provide gastro‑protective agents. Challenges: Balancing thrombosis prevention with bleeding concerns is often complex.
Hydrochlorothiazide Interaction – Concept #
Electrolyte disturbances influencing other cardiac drugs. Related terms: thiazide diuretic, hyperuricemia. Explanation: Thiazide‑induced hypokalemia heightens the risk of digoxin toxicity; increased uric acid levels can precipitate gout when combined with low‑dose aspirin. Example: Patient on HCTZ developing gout flare after starting aspirin. Practical application: Monitor serum potassium and uric acid, consider potassium‑sparing diuretics if needed. Challenges: Thiazides are first‑line antihypertensives, making avoidance difficult.
Hydroxyzine Interaction – Concept #
Additive CNS depression and anticholinergic burden when combined with other sedatives. Related terms: first‑generation antihistamine, sedation. Explanation: Hydroxyzine plus opioids or benzodiazepines can cause profound respiratory depression, especially in the elderly. Example: Elderly patient on morphine developing severe drowsiness after hydroxyzine addition. Practical application: Limit dose, avoid concurrent use where possible, and educate about sedation. Challenges: Hydroxyzine is often used for pruritus, and patients may not disclose OTC antihistamine use.
Ibuprofen Interaction – Concept #
NSAID‑induced reduction of renal prostaglandins affecting antihypertensive efficacy and renal function. Related terms: COX‑non‑selective NSAID, AKI. Explanation: Ibuprofen can blunt the effect of ACE inhibitors and diuretics, leading to fluid retention and uncontrolled hypertension; it may also precipitate acute kidney injury in volume‑depleted patients. Example: Patient on lisinopril experiencing rising BP after ibuprofen use. Practical application: Advise patients to use the lowest effective NSAID dose or select COX‑2‑selective agents with caution. Challenges: OTC availability leads to unmonitored use.
Imipramine Interaction – Concept #
CYP2D6 inhibition leading to increased levels of other substrates and additive anticholinergic effects. Related terms: tricyclic antidepressant, serotonin syndrome. Explanation: Imipramine raises plasma concentrations of metoprolol, increasing bradycardia risk; combined with SSRIs, it may precipitate serotonin syndrome. Example: Imipramine plus sertraline causing agitation and hyperreflexia. Practical application: Monitor cardiac parameters and avoid serotonergic combinations. Challenges: Depression treatment often requires multiple agents, raising interaction potential.
Insulin Interaction – Concept #
Hypoglycaemia risk when combined with agents that increase insulin sensitivity or decrease glucose production. Related terms: beta‑blockers, corticosteroids. Explanation: Beta‑blockers mask hypoglycaemic symptoms, while corticosteroids raise glucose, potentially requiring insulin dose adjustments. Example: Patient on insulin experiencing unrecognised hypoglycaemia after starting propranolol. Practical application: Educate patients on symptom recognition and adjust insulin dosing when new drugs are added. Challenges: Variable patient response to insulin makes dosing complex.
Isotretinoin Interaction – Concept #
Hepatic enzyme induction affecting steroid metabolism and increased teratogenic risk with hormonal contraceptives. Related terms: retinoid, CYP induction. Explanation: Isotretinoin induces CYP3A4, potentially reducing effectiveness of oral contraceptives, while also being highly teratogenic itself. Example: Isotretinoin therapy requiring dual contraception methods. Practical application: Prescribe non‑hormonal contraception in addition to hormonal methods. Challenges: Patient adherence to strict contraception protocols is essential but often difficult.
Lamotrigine Interaction – Concept #
Metabolism via glucuronidation; affected by enzyme inducers and inhibitors. Related terms: antiepileptic, Stevens‑Johnson syndrome. Explanation: Carbamazepine induces glucuronidation, decreasing lamotrigine levels and risking seizure breakthrough; valproic acid inhibits metabolism, raising lamotrigine levels and increasing rash risk. Example: Lamotrigine dose reduction when started on carbamazepine. Practical application: Monitor seizure frequency and skin reactions after any change. Challenges: Balancing seizure control with adverse effect risk.
Levofloxacin Interaction – Concept #
QT‑prolonging potential when combined with other torsadogenic agents and CNS stimulants. Related terms: fluoroquinolone, arrhythmia. Explanation: Levofloxacin plus methadone or anti‑psychotics can precipitate torsades de pointes, especially in patients with electrolyte abnormalities. Example: Patient on levofloxacin developing syncope due to ventricular tachycardia. Practical application: Correct electrolytes before therapy and avoid concurrent QT‑prolonging drugs. Challenges: Fluoroquinolones are often first‑line for respiratory infections, limiting alternatives.
Lithium Interaction – Concept #
Narrow therapeutic index; affected by drugs that alter renal clearance or sodium balance. Related terms: mood stabiliser, nephrogenic diabetes insipidus. Explanation: NSAIDs reduce renal prostaglandins, decreasing lithium clearance and causing toxicity; thiazide diuretics increase reabsorption, also raising lithium levels. Example: Patient on lithium developing tremor after initiating ibuprofen. Practical application: Monitor serum lithium after any change in diuretic or NSAID therapy. Challenges: Psychiatric stability may depend on lithium, making dose adjustments delicate.
Macrolide Interaction – Concept #
Broad CYP3A4 inhibition leading to elevated levels of many cardiovascular, CNS, and metabolic drugs. Related terms: azithromycin, clarithromycin. Explanation: Clarithromycin raises concentrations of statins, calcium channel blockers, and certain anti‑arrhythmics, increasing risk of myopathy and arrhythmia. Azithromycin has minimal CYP effect and may be preferred. Example: Clarithromycin plus atorvastatin causing muscle pain. Practical application: Select azithromycin when possible; otherwise, adjust statin dose. Challenges: Resistance patterns may limit use of azithromycin.
Metformin Interaction – Concept #
Risk of lactic acidosis when combined with drugs that impair renal function or increase contrast exposure. Related terms: biguanide, contrast media. Explanation: Iodinated contrast agents can precipitate acute kidney injury, reducing metformin clearance and raising lactic acidosis risk. Example: Patient receiving CT scan with contrast while on metformin developing metabolic acidosis. Practical application: Discontinue metformin 48 hours before contrast administration and resume after renal function confirmation. Challenges: Many patients undergo imaging without informing prescribers of metformin use.
Methadone Interaction – Concept #
QT prolongation and respiratory depression when combined with other CNS depressants or QT‑prolonging drugs. Related terms: opioid substitution, serotonin syndrome. Explanation: Concomitant use of methadone with fluconazole (CYP3A4 inhibitor) raises methadone levels, increasing sedation; combining with anti‑psychotics can prolong QT interval. Example: Methadone plus haloperidol causing torsades. Practical application: ECG monitoring and dose adjustments when initiating interacting agents. Challenges: Opioid dependence treatment often requires multiple concurrent medications.
Metoprolol Interaction – Concept #
Metabolism via CYP2D6; inhibitors increase plasma levels, leading to bradycardia and hypotension. Related terms: beta‑blocker, phenytoin. Explanation: Fluoxetine (CYP2D6 inhibitor) raises metoprolol concentrations, potentially causing severe bradycardia; inducers like carbamazepine reduce its effect. Example: Patient on metoprolol experiencing dizziness after starting fluoxetine. Practical application: Monitor heart rate and adjust beta‑blocker dose accordingly. Challenges: Many antidepressants are CYP2D6 inhibitors, making co‑prescribing frequent.
Methotrexate Interaction – Concept #
Reduced renal clearance and increased toxicity when combined with NSAIDs, PPIs, or proton pump inhibitors. Related terms: antifolate, bone marrow suppression. Explanation: NSAIDs compete for renal tubular secretion, raising methotrexate serum levels and risk of mucositis and myelosuppression. Example: Patient on low‑dose methotrexate for rheumatoid arthritis developing pancytopenia after ibuprofen use. Practical application: Avoid NSAIDs, use alternative analgesics, and monitor blood counts. Challenges: Pain management in inflammatory conditions often relies on NSAIDs.
Minocycline Interaction – Concept #
Inhibition of CYP2D6 leading to increased levels of certain antidepressants and antipsychotics. Related terms: tetracycline, hyperpigmentation. Explanation: Minocycline raises plasma concentrations of duloxetine, potentially causing serotonin syndrome. Example: Patient on duloxetine experiencing agitation after starting minocycline. Practical application: Consider alternative antibiotics or dose adjustments. Challenges: Minocycline is sometimes chosen for acne, where alternatives may be less effective.
Montelukast Interaction – Concept #
Minimal CYP involvement; interactions primarily pharmacodynamic with other leukotriene modifiers. Related terms: leukotriene receptor antagonist, asthma. Explanation: Concurrent use with zileuton (5‑lipoxygenase inhibitor) may increase risk of hepatotoxicity. Example: Patient on both agents developing elevated liver enzymes. Practical application: Monitor liver function tests when dual therapy is unavoidable.